Biotech Stock MESO Faces Mounting Technical Pressure

Shares of Australian biotechnology firm Mesoblast Limited experienced significant downward momentum in recent trading sessions. The company’s stock listed on the Australian exchange closed at $2.21 yesterday, marking a 4.74% decline from its opening price of $2.32. Trading activity remained volatile throughout the session, with the share price moving within a 5.45% range between a daily low of $2.20 and a high of $2.32. Mirroring this performance, Mesoblast’s NASDAQ-listed American Depositary Receipts (MESO) also declined, falling 1.22% to settle at $15.37.

Market technicians point to multiple concerning patterns that suggest sellers remain in control of Mesoblast’s equity trajectory. Several key technical indicators have recently generated bearish signals:

• A pivot top sell signal identified on July 24, 2025, continues to indicate persistent selling pressure
• The... Read more...